Independent journal index · Open data
OpenAlex CC0 · DOAJ CC0 · Open data
Subscription Possibly ceased · 2019

Drug Designing Open Access

DDO · Drug design

ISSN-L 2169-0138

OMICS Publishing Group · United States · 2012

Submission → publication—
APC—
DOAJ—
Earliest year2012

Limited public data

Neither OpenAlex nor DOAJ has enough records for this journal: no submission link, no fee or timeline, and very few articles. It may be new, small, ceased, or simply not documented. Please verify with the publisher or the links below.

Master Journal List ↗ · Google Scholar ↗ · DOAJ ↗

Basic information

Publisher
OMICS Publishing Group · United States
Country/Region
United States
Subject
Pharmacology, Toxicology and Pharmaceutics
Open access
—
DOAJ
—
License
—
Earliest year
2012
DOAJ article records
—
Journal website
http://www.omicsgroup.org/journals/articleinpre…
Verify this journal
ISSN Portal ↗ · Master Journal List ↗
✓ ISSN checksum valid
Submission page
—

Common questions

How much does it cost to publish in Drug Designing Open Access?
The data sources do not list an APC for this journal. Check the journal's author guidelines.
Is Drug Designing Open Access open access?
No — it is indexed as a subscription journal.
Is Drug Designing Open Access still publishing?
Probably not — the most recent recorded output is from 2019.

Correct a record · Request removal

Subject classification

Pharmacology, Toxicology and Pharmaceutics106 Chemistry41 Materials Science27 Biochemistry, Genetics and Molecular Biology19 Medicine16
§

Journals in the same subject

More →
0114-9954

Reactions Weekly

Adis, Springer Healthcare · New Zealand

APC
—
Time to publish
—
Articles/yr
—
0041-0101

Toxicon

Elsevier BV · United Kingdom

APC
$3,340
Time to publish
—
Articles/yr
—
1999-4923
OA DOAJ

Pharmaceutics

Multidisciplinary Digital Publishing Institute · Switzerland

APC
$3,277
Time to publish
6 weeks
Articles/yr
—